HHS Secretary Robert F. Kennedy Jr. on Wednesday appointed eight new members to the Advisory Committee on Immunization Practices (ACIP), which advises CDC on vaccines, two days after he fired all 17 members from the committee. Here's who's on the panel.
On Monday, Kennedy fired all 17 members of ACIP, arguing in an opinion piece for the Wall Street Journal that ACIP has been "plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine," adding that ACIP has "never recommended against a vaccine — even those later withdrawn for safety reasons" and has "failed to scrutinize vaccine products given to babies and pregnant women."
While Kennedy argued the financial conflicts of interest were cause for the firings, a White House official and person close to Kennedy said on Tuesday to the New York Times that Kennedy was also concerned that all the members had been appointed by former President Joe Biden and that some had donated to Democrats.
In a post on X, Kennedy announced the eight doctors and researchers who would be part of ACIP, saying his picks included "highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians." All of Kennedy's picks are either medical doctors or doctorates.
The new ACIP members include:
Kennedy said the new members will attend ACIP's next meeting, which is scheduled for June 25, and that they will demand "definitive safety and efficacy data before making any new vaccine recommendations." ACIP will also "review safety and efficacy data for the current schedule as well," Kennedy added.
Following the announcement, several infectious disease and vaccine experts accused Kennedy of breaking his word that he wouldn't appoint "ideological anti-vaxxers" to ACIP and expressed concerns about some of the appointments.
"I think everybody is expecting that what we're going to start seeing is the rollback of the recommendations," said Sara Rosenbaum, a professor emerita of public health law at George Washington University.
"This was all a prelude to a takeover of the process by which the recommendations and the schedule are built," she said. "And now what we're going to start seeing is changes to the recommendations on the schedule for both [the Vaccines for Children Program] and for private insurance."
Paul Offit, a vaccine expert at the Children's Hospital of Philadelphia, who previously served as a member of ACIP, said he was mainly concerned about the appointments of Pebsworth and Malone who, he said, "is a clear anti-vaccine activist."
As for the rest of the committee, Offit said "they seem reasonable — what they lack, it seems to me, is the kind of expertise or experience in vaccines that was on that committee. I think we lost experience, expertise, and institutional memory, and so I think we've taken a giant step backward in terms of the kind of advice that we're going to be getting. And I wonder whether the medical and scientific community will look at this committee now and not trust their advice."
Abram Wagner, from the University of Michigan's school of public health who investigates vaccination programs, said he's not happy with the appointments.
"The previous ACIP was made up of technical experts who have spent their lives studying vaccines," he said, adding that most of the appointees "don't have the technical capacity that we would expect out of the people who would have to make really complicated decisions involving interpreting complicated scientific data."
However, Offit and other experts specifically praised Meissner for his depth of vaccine knowledge. Richard Hughes, who teaches vaccine law at George Washington University Law School, called Meissner a "legitimate vaccinologist."
Hughes said three of the new members are "legitimate physicians" who have "no discernible expertise" in immunology or vaccines. But he characterized the remaining four as "Covid-19 deniers, skeptics and outright anti-vaccine individuals."
(Stolberg, New York Times, 6/11; Lawrence et al., STAT+ [subscription required], 6/11; Cirruzzo et al., STAT, 6/11; Fiore, MedPage Today, 6/11)
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.